Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, August 23, 2022
[ Tue, Aug 23rd 2022
] - WOPRAI
[ Tue, Aug 23rd 2022
] - WOPRAI
[ Tue, Aug 23rd 2022
] - WOPRAI
[ Tue, Aug 23rd 2022
] - WOPRAI
[ Tue, Aug 23rd 2022
] - WOPRAI
[ Tue, Aug 23rd 2022
] - WOPRAI
[ Tue, Aug 23rd 2022
] - WOPRAI
Mon, August 22, 2022
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
[ Mon, Aug 22nd 2022
] - WOPRAI
Ed Arce Maintained (VERA) at Strong Buy with Increased Target to $36 on, Aug 22nd, 2022
Ed Arce of HC Wainwright & Co., Maintained "Vera Therapeutics, Inc." (VERA) at Strong Buy with Increased Target from $35 to $36 on, Aug 22nd, 2022.
Ed has made no other calls on VERA in the last 4 months.
There is 1 other peer that has a rating on VERA. Out of the 1 peers that are also analyzing VERA, 0 agree with Ed's Rating of Hold.
This is the rating of the analyst that currently disagrees with Ed
- Anupam Rama of "JP Morgan" Initiated at Buy and Held Target at $35 on, Tuesday, July 12th, 2022
